iGEM 2017 — Team Manchester

[![](https://static.igem.org/mediawiki/2017/8/8b/HQ_page_logo.jpg)](https://2017.igem.org)

# Team:Manchester/Notebook

[[![](https://static.igem.org/mediawiki/2017/b/b1/T--Manchester--igemspinninglogo.gif)

## PHOSPHOSTORE](https://2017.igem.org/Team%3AManchester)](https://2017.igem.org/Team%3AManchester)

* [Project](https://2017.igem.org/Team%3AManchester/Description)
  + [Overview](https://2017.igem.org/Team%3AManchester/Description)
  + [Description](https://2017.igem.org/Team%3AManchester/Description1)
  + [Results](https://2017.igem.org/Team%3AManchester/Results)
  + [Demonstration](https://2017.igem.org/Team%3AManchester/Demonstrate)
  + [Medal Criteria](https://2017.igem.org/Team%3AManchester/Medals)
  + [Achievement](https://2017.igem.org/Team%3AManchester/Achievement)
  + [☆JUDGING FORM☆](https://igem.org/2017_Judging_Form?team=Manchester)
* [Modelling](https://2017.igem.org/Team%3AManchester/Model)
  + [Overview](https://2017.igem.org/Team%3AManchester/Model)
  + [D. o. Experiment](https://2017.igem.org/Team%3AManchester/Model/DoE)
  + [Cont. Culture](https://2017.igem.org/Team%3AManchester/Model/Continuous_Culture)
  + [PHO Operon](https://2017.igem.org/Team%3AManchester/Model/PSO)
* [Parts](https://2017.igem.org/Team%3AManchester/Parts)
  + [Overview](https://2017.igem.org/Team%3AManchester/Parts)
  + [Basic Parts](https://2017.igem.org/Team%3AManchester/Basic_Part)
  + [Composite Parts](https://2017.igem.org/Team%3AManchester/Composite_Part)
  + [Improved Parts](https://2017.igem.org/Team%3AManchester/Improve)
  + [Part Collection](https://2017.igem.org/Team%3AManchester/Part_Collection)
* [Notebook](https://2017.igem.org/Team%3AManchester/Notebook)
  + [Diary](https://2017.igem.org/Team%3AManchester/Diary)
  + [Protocols](https://2017.igem.org/Team%3AManchester/Experiments)
  + [Lab book](https://2017.igem.org/Team%3AManchester/Notebook)
  + [InterLab](https://2017.igem.org/Team%3AManchester/InterLab)
  + [Measurement](https://2017.igem.org/Team%3AManchester/Measurement)
* [Human Practices](https://2017.igem.org/Team%3AManchester/HP/Silver)
  + [Human Practices](https://2017.igem.org/Team%3AManchester/HP/Silver)
  + [Integrated Practices](https://2017.igem.org/Team%3AManchester/HP/Gold_Integrated)
  + [Public Engagement](https://2017.igem.org/Team%3AManchester/Engagement)
  + [Water Industry](https://2017.igem.org/Team%3AManchester/HP/Water_Industry)
  + [Intellectual Property](https://2017.igem.org/Team%3AManchester/HP/Intellectual_Property)
  + [Entrepreneurship](https://2017.igem.org/Team%3AManchester/Entrepreneurship)
* [Team](https://2017.igem.org/Team%3AManchester/Team)
  + [Team](https://2017.igem.org/Team%3AManchester/Team)
  + [Collaborations](https://2017.igem.org/Team%3AManchester/Collaborations)
  + [Attributions](https://2017.igem.org/Team%3AManchester/Attributions)

MENU

[HOME](https://2017.igem.org/Team%3AManchester)

TEAM

[Team](https://2017.igem.org/Team%3AManchester/Team)
[Collaborations](https://2017.igem.org/Team%3AManchester/Collaborations)
[Attributions](https://2017.igem.org/Team%3AManchester/Attributions)

PROJECT

[Overview](https://2017.igem.org/Team%3AManchester/Description)
[Description](https://2017.igem.org/Team%3AManchester/Description1)
[Results](https://2017.igem.org/Team%3AManchester/Results)
[Demonstration](https://2017.igem.org/Team%3AManchester/Demonstrate)
[Medal Criteria](https://2017.igem.org/Team%3AManchester/Medals)
[Achievement](https://2017.igem.org/Team%3AManchester/Achievement)

NOTEBOOK

[Protocols](https://2017.igem.org/Team%3AManchester/Experiments)
[Diary](https://2017.igem.org/Team%3AManchester/Diary)
[Lab Book](https://2017.igem.org/Team%3AManchester/Notebook)
[InterLab](https://2017.igem.org/Team%3AManchester/InterLab)
[Measurement](https://2017.igem.org/Team%3AManchester/Measurement)

PARTS

[Parts](https://2017.igem.org/Team%3AManchester/Parts)
[Basic Parts](https://2017.igem.org/Team%3AManchester/Basic_Part)
[Composite Parts](https://2017.igem.org/Team%3AManchester/Composite_Part)
[Improved Parts](https://2017.igem.org/Team%3AManchester/Improve)
[Part Collection](https://2017.igem.org/Team%3AManchester/Part_Collection)

HUMAN PRACTICES

[Silver HP](https://2017.igem.org/Team%3AManchester/HP/Silver)
[Water Industry](https://2017.igem.org/Team%3AManchester/HP/Gold_Integrated)
[Integrated and Gold](https://2017.igem.org/Team%3AManchester/HP/Water_Industry)
[Intellectual Property](https://2017.igem.org/Team%3AManchester/HP/Intellectual_Property)
[Public Engagement](https://2017.igem.org/Team%3AManchester/Engagement)
[Entrepreneurship](https://2017.igem.org/Team%3AManchester/Entrepreneurship)

MODELLING

[Overview](https://2017.igem.org/Team%3AManchester/Model)
[D. O. Experiment](https://2017.igem.org/Team%3AManchester/Model/DoE)
[Continuous Culture](https://2017.igem.org/Team%3AManchester/Model/Continuous_Culture)
[PHO Operon](https://2017.igem.org/Team%3AManchester/Model/PSO)

[JUDGING FORM](https://igem.org/2017_Judging_Form?team=Manchester)

## 🍀 Lab Plan 🍀

#### Polyphosphate Kinase (PPK) Fusion Protein

---

Basic aim: Assess impact localisation tag has on kinetics of PPKs

### **Introduction**

Our project initially aimed to screen a selection of bacterial polyphosphate kinases to select one with the greatest forward rate of reaction (polyphosphate formation). Due to time constraints, we have decided to focus on a single polyphosphate kinase (PPK) that we identified in the Brenda database. We chose a PPK from Corynebacterium glutamicum, a bacteria used for industrial production of amino acids. The bacteria was discovered to accumulate high concentrations of polyphosphate (600mM, 37% cell volume), which was largely attributed to its class II Polyphosphate kinase. This PPK (encoded by NCgl2620) has a Kcat value of 74 for ATP ➝ Poly P under the experimental conditions used. It is also fully soluble, unlike the E. coli PPK which was encapsulated within a Pdu microcompartment by Warren et al. earlier this year. We hypothesise that solubility may enhance efficiency of encapsulation.

At this stage we will only be trialing one localisation tag (PduD1-20) and hope to characterise it using mCherry and fluorescence microscopy as an indicator for incorporation into microcompartment.

We were planning on ordering these sequences as gBlocks and simultaneously cloning them into both the submission vector and the expression vector pNIC-bsa28 in frame with a T7 promoter. Then we can over-express these fusion proteins in BL21 (DE3) cells and purify them using a nickel affinity resin column.

After expression and purification, the enzymes constructs will be characterised via Michaelis-Menten kinetics using the Promega ADP-Glo™ Kinase Assay. Technical support from Promega confirmed that the kit should work on a polyphosphate kinase. Promega have kindly provided us with 400 assays to use free of charge.

Kinetics data generated from these assays will allow us to assess any impact the localisation tag or mCherry tag has on enzyme activity. Results from this will aid how we build the construct to target the enzyme into the microcompartment at a later stage.

### **Experimental Plan**

a. Design and order the following constructs with EcoRI, XbaI prefix, SpeI, PstI and XhoI suffix (XhoI will be used to go into pNIC28):

- (N)tag\_mCherry\_PPK\_His6

- (N)tag\_PPK\_mCherry\_His6

- PPK\_His6

b. Resuspend powder gBlocks (1000 ng) in 20 uL EB buffer (miniprep kit)

c. Clone PPK gBlocks into pNIC28 (PPKs in pNIC28) and pSB1C3 (PPKs in pSB1C3):

1. Restriction digest pSB1C3 with EcoRI and PstI, pNIC28 with XbaI and XhoI and the PPK constructs (some for pSB1C3, some for pNIC28)

2. Perform ligation reaction 3 : 1 (~50ng vector)

3. Transform into DH5a cells

4. Overnight cultures

5. Miniprep plasmid

6. Restriction digest some of the ligated plasmid and run agarose gel to confirm insert **(Table 1)**

**Table 1: Expected results from restriction digest of all PPK constructs**

| Construct | Digest with | Expected fragment size (bp) |
| pSB1C3\_PPK\_His | EcoRI + PstI | 2029 + 1121 |
| pSB1C3\_PduD\_mCherry\_PPK\_His | PstI + HindIII | 2596 + 1337 |
| pSB1C3\_PduD\_PPK\_mCherry\_His | EcoRI + HindIII | 2439 + 1494 |
| pNIC28\_PPK\_His | XbaI + XhoI | 5192 + 1111 |
| pNIC28\_PduD\_mCherry\_PPK\_His | XbaI + XhoI | 5192 + 1894 |
| pNIC28\_PduD\_PPK\_mCherry\_His | XbaI + XhoI | 5192 + 1894 |

7. Send all constructs for sequencing

8. Submit pSB1C3 constructs as new BioBricks

9. Transform pNIC28 constructs into BL21(DE3) cells for expression

10. Colony PCR and agarose gel - to confirm ligated plasmid is present

11. Grow each of the confirmed transformants in TB

12. Purify protein using nickel resin

13. Measure specific activity of enzyme using ADP-Glo™ Kinase Assay kit

14. Determine kinetics with respect to PO4-

15. Upload characterization data for submitted parts

#### Eut Microcompartment

---

Basic aim: Form a Eut bacterial microcompartment (BMC)

Hopefully: Optimise BMC formation

### **Introduction**

We initially considered using a Pdu (1,2-propanediol utilisation) microcompartment to package our enzyme, as it is well characterised in literature. However, after consulting our supervisors and PIs, we have decided to use Eut (Ethanolamine utilisation) microcompartments for our experiments. This contrasts the paper which inspired our project (Liang M, et al., 2017), but follows on from the 2013 HongKong iGEM teams work (link wiki). The Eut microcompartment functions as a site where ethanolamine is cleaved into ammonia and acetaldehyde in bacteria such as Citrobacter and Salmonella. This is achieved through the action of ethanolamine-ammonia lyase, which is localised inside the microcompartment.

Localisation of proteins like the aforementioned enzyme requires the presence of a Eut signal sequence/ tags - a short sequence of 18-20 amino acids that is located at the N-terminal of the protein of interest. From literature and through consultation, we have found that EutC1-19, EutD1-20, and EutE1-20 seem to be the most well characterised of these sequences. Additionally, due to the relatedness of Eut and Pdu, Pdu signal sequences PduD1-20 and PduP1-18 may also be able to localize proteins inside Eut microcompartments.

In order to accurately control and optimise the formation of BMCs, we want to build the following circuits to express the Eut proteins S, M, N, L, K under the control of inducible promoters. The operon has been split into 3 sections: each part has been designed and is ready to order as gBlocks from IDT. **(Table 2)**.

**Table 2: Eut constructs**

| Part | Details | Length (bp) |
| lacUV5\_EutS | IPTG inducing lacUV5 promoter causing EutS synthesis. N term His tag on EutS. | 1983 |
| tetA\_EutMN | Tetracyclin inducing TetA promoter causing GFP-EutM and EutN synthesis. N term His tag on GFP-EutM; C term FLAG tag on EutN. | 2452 |
| araBAD\_EutLK | Arabinose inducing araBAD promoter causing EutL and EutK synthesis. N term His tag on EutL; C term FLAG tag on EutK. | 2740 |

**Figure 1: Three Eut operons. (From top to bottom) lacUV5\_EutS, tetA\_EutMN and araBAD\_EutLK**

![](https://static.igem.org/mediawiki/2017/2/27/T--Manchester--3eutoperons.png)

**Table 3: Sizes of Eut proteins with and without tags**

| Eut protein | Length (a.a.) | Size (kDa) | Tags | Size with tags (kDa) |
| S | 111 | 11.6 | NTerm His6 | 12.70 |
| M | 97 | 9.4 | NTerm His6 + GFP | 40.12 |
| N | 95 | 10.0 | CTerm FLAG | 11.20 |
| L | 219 | 22.8 | NTerm His6 | 23.92 |
| K | 166 | 17.9 | CTerm FLAG | 19.10 |

### **Experimental Plan**

a. Order 3 Eut parts as gBlocks from IDT

b. Clone each Eut part into pSB1C3:

1. Restriction digest pSB1C3, Lac\_EutS, Tet\_EutMN, and ara\_EutLK with EcoRI and PstI

2. Perform the 3 ligation reactions (+ 2 controls)

3. Transform into DH5a cells (from NEB)

4. Overnight cultures

5. Miniprep plasmid

6. Restriction digest some of the ligated plasmid and run agarose gel to confirm insert **(Table 4)**

**Table 4: Expected results from restriction digest of all Eut constructs**

| Construct | Digest with | Expected fragment size (bp) |
| pSB1C3\_lac\_EutS | XhoI | 1700 + 1405 + 892 |
| pSB1C3\_tetR\_EutMN | NcoI | 2655 + 1808 |
| pSB1C3\_araBad\_EutLK | BamHI | 3830 + 925 |

7. Send all constructs for sequencing (Sanger sequencing - Eurofins Genomics)

8. Submit pSB1C3 constructs as new BioBricks

9. Transform pSB1C3 Eut constructs into DH5a cells for expression

10. Colony PCR and agarose gel - to confirm ligated plasmid is present

11. Overnight cultures of each of the confirmed transformants in TB

12. Induce expression of each construct

13. Check construct expression by western blot

c. Assemble the Eut operon in pSB1C3 using BioBrick cloning sites:

1. Restriction digest pSB1C3\_Lac\_EutS with SpeI + PstI and pSB1C3\_TetR\_EutMN with XbaI + PstI

2. Run on agarose gel and gel extract band of pSB1C3\_Lac\_EutS at ~4000bp, and band of TetR\_EutMN at ~2400bp

3. Ligation reaction = to form pSB1C3\_Lac\_EutS\_TetR\_EutMN

4. Transform into DH5a cells

5. Overnight culture

6. Miniprep

7. Restriction digest with EcoRI + PstI

8. Run agarose gel to confirm successful insert - looking for bands at 4369bp + 2029bp, and send for sequencing

9. Restriction digest pSB1C3\_Lac\_EutS\_TetR\_EutMN with SpeI + PstI and pSB1C3\_araBad\_EutLK with XbaI + PstI

10. Run on agarose gel and gel extract band of pSB1C3\_Lac\_EutS\_TetR\_eutMN at 6383bp, and band of araBad\_eutLK at 2708bp

11. Ligation reaction = to form pSB1C3\_Lac\_EutS\_TetR\_EutMN\_araBad\_EutLK

12. Transform into DH5a cells

13. Colony PCR, and run agarose gel

14. Overnight culture

15. Miniprep

16. Restriction digest with NcoI to confirm successful insert - look for bands at 5348bp and 3743bp **(Table 5)**

17. Send for sequencing (Sanger sequencing - Eurofins Genomics)

18. Submit pSB1C3\_Lac\_EutS\_TetR\_EutMN\_araBad\_EutLK as BioBrick

**Table 5: Expected result from restriction digests during Eut operon assembly**

| Construct | Digest with | Expected fragment size (bp) |
| pSB1C3\_Lac\_EutS\_TetR\_EutMN | EcoRI + PstI | 4369 + 2029 |
| pSB1C3\_Lac\_EutS\_TetR\_EutMN\_araBad\_EutLK | NcoI | 5348 + 3743 |
| pSB4A5\_Lac\_EutS\_TetR\_EutMN\_araBad\_EutLK | PstI + EcoRI | 7062 + 3354 |

d. Expression of Eut operon:

1. PCR the Eut operon out of pSB1C3 (VR, VF2)

2. Restriction digest Eut operon and pSB4A5 with EcoRI + PstI

3. Ligation reaction = to form pSB4A5\_LacEutS\_TetEutMN\_araEutLK

4. Transform into DH5a cells

5. Colony PCR and agarose gel

6. Overnight culture

7. Miniprep plasmid

8. Restriction digest with EcoRI + PstI (Table 5) and run agarose gel to confirm insert

9. Send for sequencing to ensure no mutation

10. Grow each of the confirmed transformants in TB

11. Induce pSB4A5\_Lac\_EutS\_TetR\_EutMN\_araBad\_EutLK

12. Confirm expression of all Eut proteins via western blot

13. Fluorescence microscopy to visualise and confirm BMC formation - this will be the empty BMC

#### Localisation Tag Characterisation

---

Basic aim: Encapsulate mCherry tagged with the signal sequences inside the Eut microcompartment

### **Introduction**

Successful encapsulation would be justified by fluorescence microscopy using colocalisation technique, which involves the observation of the spatial overlap between two different fluorescent labels, i.e. mCherry and GFP, each having a separate emission wavelength. Microcompartments carry GFP while the localisation tags carry mCherry.

### **Experimental Plan**

a. PCR out the RBS\_PduD 1-20\_mCherry constructs from existing constructs in the lab. The constructs were in a pET-DUET plasmid.

b. Cloning:

1. Cut all tag constructs with EcoRI and PstI to clone into pSB1C3 submission vector with medium strength constitutive promoter (BioBrick: BBa\_J23108).

2. Do a restriction digest. Cut the promoter vector (pSB1C3 which contains the promoter BBa\_J23108) with SpeI and PstI and cut the PCR product with XbaI and PstI. Use a phosphatase to cleave the 5’ phosphate in the promoter vector.

c. Removal of the illegal Xba1 site from all PduD1-20 constructs ([BBa\_K2213006-BBa\_K2213008](https://2017.igem.org/Team%3AManchester/Basic_Part)).

d. Sequence and submit all PduD 1-20 constructs with different strength anderson promoters as [improved parts](https://2017.igem.org/Team%3AManchester/Improve).

e. Confirm expression - agarose gel electrophoresis.

**Selecting constitutive promoters from the registry**

We have chosen medium, strong and weak constitutive promoters for expression of the tag-mcherry parts:

- Part:BBa\_J23108 - strength = 0.51 - plate 4 - well 4C

- Part:BBa\_J23104 - strength = 0.72 - plate 4 - well 17L

- Part:BBa\_J23105 - strength = 0.24 - plate 4 - well 17N

The strong and weak promoters (Part:BBa\_J23104 and Part:BBa\_J23105) are in the backbone BBa\_J61002 (not pSB1C3) so we will get these synthesised as primers instead to reduce the amount of cloning we have to do. This will allow us to express promoter at different levels during design of experiment.

**For low and high strength promoters:**

BBa\_J23104 and BBa\_J23105 are in the plasmid BBa\_J61002 and we want them in the pSB1C3:

1. Cut at EcoRI and SpeI to cut out promoter from plasmid BBa\_J61002.

2. PCR the promoter extracted.

3. Cut pSB1c3 at EcoRI and SpeI and ligate the promoter in.

4. Constructs ready to be used in Eut DoE experiments.

#### Eut Design of Experiment (DoE)

---

Basic aim: Optimise BMC formation

Modelling: Design of Experiments is used to find the optimal parameters using minimal tests by simultaneously changing multiple factors and making justified changes as the experiment is repeated. As the experiment is repeated, fundamental factors are identified and the next round of experiments hone in on these. By structuring our experiments and data in this way, we will be able to gain a deeper insight into to interactions and factors influencing our data. A general linear model can then be fitted (using JMP).

Response: Function of formation of microcompartments

**Table 7: DoE Input Factors**

| Name | Type of factor (categorical or continuous) | Difficulty (e, m, h, vh) | Range | Variables |
| Temperature | con |  | 15 - 37 °C |  |
| pH | con |  | 4.0 (E.coli strain M23) |  |
| Copy number of plasmid | cat |  |  |  |
| Tags x 5 + empty (6) | cat | e | n/a |  |
| Cell type | cat |  | BL21, DH5a |  |
| Strength of Anderson promoters | con |  | 0.24, 0.51, 0.72 |  |
| Time of BMC induction | con |  |  |  |
| Time of BMC harvesting | con |  |  |  |
| RPM in shaker (aeration) | con |  |  |  |
| Carbon source | cat |  |  |  |
| Iron conc | con |  |  |  |
| Phosphate conc | con |  |  |  |
| Magnesium conc | con |  |  |  |
| Carbon conc | con |  |  |  |
| Calcium conc | con |  |  |  |
| Organic solvent conc | con |  |  |  |
| Cell density | con |  |  |  |
| Secondary metabolite conc | con |  |  |  |
| ammonia/ammonium conc | con |  |  |  |
| Eut plasmid | cat |  | Maybe: plyss, pacyc duet, pET duet, pSB4A5 |  |
| Concentration of inducers used for the promoters in the Eut operon | con |  | IPTG: 0-100 uM |  |

**Table 8: DoE Responses**

| Name | Response type / range | Other information |
| Final OD (optical density) |  |  |
| Objects ranked by circularity automatically using imageJ |  | [Reference](https://imagej.nih.gov/ij/plugins/circularity.html) |
| Software automated - mCherry/GFP ratio analysis to determine co-localization of tag in BMC |  | [Reference](https://imagej.nih.gov/ij/plugins/track/jacop.html) |
| Similarity to template BMC ranked by software |  | [Reference](https://imagej.nih.gov/ij/plugins/template-matching.html) |

## ⍟ Actual Lab Work Record ⍟

Toggle mini / wide pdf size

**If the browser does not support embedded PDFs**: Please download the PDF to view it.

#### PPK

[Download PDF](https://static.igem.org/mediawiki/2017/9/9d/T--Manchester--test.pdf).

#### Eut

[Download PDF](https://static.igem.org/mediawiki/2017/9/90/Eutlabbookrecordmanchester.pdf).

#### Tag

[Download PDF](https://static.igem.org/mediawiki/2017/7/7e/Tagslabbookrecordmanchester.pdf).

![](https://static.igem.org/mediawiki/2017/a/aa/T--Manchester--manchesterigem2017logo.jpg)
[![See your web site through colorblind eyes with the colorblind web page filter.](https://www.toptal.com/designers/colorfilter/static/colorfilter_button.png "Website optimised for colorblindness")](https://www.toptal.com/designers/colorfilter)

Connect with us:

Email: manchesterigem17@gmail.com

[![](https://static.igem.org/mediawiki/2017/2/22/T--Manchester--UOM.png)](http://www.mib.ac.uk/)
[![](https://static.igem.org/mediawiki/2017/a/a7/T--Manchester--sponsor_uom.png)](http://www.manchester.ac.uk/)
[![](https://static.igem.org/mediawiki/2017/e/ed/T--Manchester--sponsor_mmu.svg)](http://www2.mmu.ac.uk/)
[![](https://static.igem.org/mediawiki/2017/3/37/T--Manchester--sponsor_snapgene.png)](http://www.snapgene.com/)
[![](https://static.igem.org/mediawiki/2017/c/c2/T--Manchester--sponsor_mathworks.svg)](https://www.mathworks.com/)
[![](https://static.igem.org/mediawiki/2017/f/f2/T--Manchester--IDTLOGO.png)](https://www.idtdna.com/site)
[![](https://static.igem.org/mediawiki/2017/f/fc/T--Manchester--NEBsponsorlogo.jpg)](https://www.neb.com/)
[![](https://static.igem.org/mediawiki/2017/0/00/T--Manchester--sponsor_agilent.png)](http://www.agilent.com/home)
[![](https://static.igem.org/mediawiki/2017/3/3a/T--Manchester--sponsor_promega.svg)](https://www.promega.co.uk/)
[![](https://static.igem.org/mediawiki/2017/0/0e/T--Manchester--sponsor_biocatnet.png)](http://biocatnet.com/)
[![](https://static.igem.org/mediawiki/2017/f/f9/T--Manchester--sponsor_ibcarb.png)](http://ibcarb.com/)

[![](https://static.igem.org/mediawiki/2017/b/bf/HQ_menu_logo.jpg)](https://2017.igem.org)